Home Tags Purdue Pharma
Tag: Purdue Pharma
The family behind OxyContin pocketed $10.7 billion from Purdue Pharma. Meet the Sacklers, who built their $13 billion fortune off the controversial op...
Many say that OxyContin, the source of the Sackler family's enormous wealth, has fueled the US opioid crisis.
Dispensed: How retailers are beefing up their health ambitions, insights from Purdue Pharma’s bankruptcy filing, and a looming shortage of OB-GY...
Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
‘My husband died on heroin’: Courtney Love lashed out at an OxyContin heir who she claims offered her money to attend a fashion show
Courtney Love told Page Six that as "one of the most famous reformed junkies on the planet," she didn't plan to "sell out" to Joss Sackler's offer.
Purdue Pharma and its billionaire owners may end up giving billions in OxyContin profits to communities harmed by the opioid crisis
The proposal would mark a departure from the fates of other companies accused of stoking public-health crises.
Purdue Pharma is reportedly mulling an 8-figure settlement to resolve more than 2,000 opioid cases — and it would plunge the drugmaker into bank...
The settlement talks follow an Oklahoma judge's ruling against Johnson & Johnson in a similar case earlier this week.
Non-profits, museums, and hedge funds: Here are the groups that have cut ties with the Sackler family over the opioid crisis
Universities, museums, and nonprofits are rejecting members of the family and financial gifts because the Sacklers own Purdue Pharma and OxyContin.
Pharo Management, a UK-based hedge fund told investors it returned $300 million to Saudi Arabia in a rare rebuke to the oil giant, according to Bloomberg.
The UK’s top galleries are refusing donations from the Sacklers, the wealthy US family behind OxyContin
The Sackler family is facing legal action for allegedly helping create the US opioid crisis.
Opioid overdose deaths are highest in places where pharma spends the most on marketing, a new study finds
Researchers at the University of Pittsburgh launched a study to figure out if there's a link between the money that drugmakers spend on opioid marketing and drug-related deaths.
Starting in 2018, the health insurer will no longer cover OxyContin, the branded version of the painkiller oxycodone.